These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26323412)

  • 1. Neonatal Formulations: The Need for a Tailored, Knowledge Driven Approach.
    Allegaert K; Cosaert K; van den Anker JN
    Curr Pharm Des; 2015; 21(39):5674-9. PubMed ID: 26323412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered.
    Valeur KS; Holst H; Allegaert K
    Pharmaceut Med; 2018; 32(4):251-258. PubMed ID: 30174435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonates need tailored drug formulations.
    Allegaert K
    World J Clin Pediatr; 2013 Feb; 2(1):1-5. PubMed ID: 25254168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology in neonates: small size, huge variability.
    Allegaert K; van den Anker JN
    Neonatology; 2014; 105(4):344-9. PubMed ID: 24931327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version.
    Salunke S; Brandys B; Giacoia G; Tuleu C
    Int J Pharm; 2013 Nov; 457(1):310-22. PubMed ID: 24070789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmful excipients in medicines for neonates in Spain.
    Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
    Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
    Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
    Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cumulative Daily Tolerance Levels of Potentially Toxic Excipients Ethanol and Propylene Glycol Are Commonly Exceeded in Neonates and Infants.
    Valeur KS; Hertel SA; Lundstrøm KE; Holst H
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):523-530. PubMed ID: 29281181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
    Nasrollahi S; Meera NK; Boregowda S
    Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why are Excipients Important to Neonates?
    Turner MA; Shah U
    Curr Pharm Des; 2015; 21(39):5680-7. PubMed ID: 26323411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosing Guidelines of Aminoglycosides in Neonates: A Balance Between Physiology and Feasibility.
    Allegaert K; Cossey V; van den Anker JN
    Curr Pharm Des; 2015; 21(39):5699-704. PubMed ID: 26323409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal drug therapy: The first frontier of therapeutics for children.
    Allegaert K; van den Anker J
    Clin Pharmacol Ther; 2015 Sep; 98(3):288-97. PubMed ID: 26095519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
    Shehab N; Lewis CL; Streetman DD; Donn SM
    Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria supporting the study of drugs in the newborn.
    Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
    Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better medicines for neonates: Improving medicine development, testing, and prescribing.
    Allegaert K
    Early Hum Dev; 2017 Nov; 114():22-25. PubMed ID: 28899617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.
    Sosnik A; Seremeta KP; Imperiale JC; Chiappetta DA
    Expert Opin Drug Deliv; 2012 Mar; 9(3):303-23. PubMed ID: 22257003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalised neonates in Estonia commonly receive potentially harmful excipients.
    Lass J; Naelapää K; Shah U; Käär R; Varendi H; Turner MA; Lutsar I
    BMC Pediatr; 2012 Aug; 12():136. PubMed ID: 22931304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborns and drug studies: the NICHD/FDA newborn drug development initiative.
    Giacoia GP; Mattison DR
    Clin Ther; 2005 Jun; 27(6):796-813. PubMed ID: 16117987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extemporaneous drug formulations.
    Nahata MC; Allen LV
    Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The propylene glycol research project to illustrate the feasibility and difficulties to study toxicokinetics in neonates.
    Kulo A; de Hoon JN; Allegaert K
    Int J Pharm; 2012 Oct; 435(2):112-4. PubMed ID: 22641171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.